Information Provided By: 
Fly News Breaks for February 19, 2020
BHC
Feb 19, 2020 | 11:39 EDT
Cowen analyst Ken Cacciatore reiterated an Outperform rating and $40 price target on Bausch Health following the company's fourth quarter results. Cacciatore, who noted that the 2020 guidance was in-line with his estimates, said he wants a "boring, grinding, durable, cash generating performance" from this company, not excitement. The analyst said that the more boring, the more likely he gets to his price target even faster. He added that there is no change to his thesis, as the businesses all look on track to his previous thinking.
News For BHC From the Last 2 Days
